chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse refers to at least 5 patients of unknown age and gender. On an unknown dates, since the end of 2012, the patients were vaccinated with unspecified doses of GARDASIL, intramuscular, (lot number and expiration dates not reported). which were improperly exposed to temperatures below 32F for unspecified lengths of time. No known adverse effects. Additional information has been requested.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation, referring to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and/or zoster-related conditions (strength, dose, route of administration, anatomical location, lot#, and expiration date were not reported). At the time of vaccination, the patient relied on the warning label affixed to zoster vaccine live (ZOSTAVAX), and the information relayed through the patient's healthcare provider that zoster vaccine live (ZOSTAVAX) was effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effects, which induced the patient to be vaccinated. Alternatively, in 2017, the patient's healthcare providers included but not limited to a healthcare provider, relied on the warning label affixed to the zoster vaccine live (ZOSTAVAX) vaccine, believed that it was effective in preventing shingles on a long-term or permanent basis that it did not carry any significant risks of adverse effects. On an unknown date, reported as subsequently to the vaccination, the patient was treated for shingles. The patient had and would continue suffered ongoing injuries, including but not limited to: mental and physical pain and suffering ongoing injuries; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not recovered. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
Few hours after vaccine she developed pain in arm claims gets prickling, itching sensation in arm whenever it gets warm. Also gets sharp pain in the arm and elbow lasting 10 minutes or less. Left hand gets numb. This is persisting to this day.
ONSET FEVER OF 103-RECTAL THAT PM. THE NEXT DAY TEMP WAS 102-RECTAL. NO THER SYPTOMS.
I contracted COVID-19 on 06/25/2022 with symptoms of runny nose, congestion, cough, fever of 100.8, insomnia, fatigue, and mild short lived headache. I was prescribed PAXLOVID on 06/27/2022, and began the round of anti-viral same day. The insomnia has improved, and the runny nose is becoming less frequent. I am not recovered as of yet.
Vomiting every 1 1/2 to 2 hours for 8 days.
accidentally administered expired dose of GSK meningitis b to patient. patient notified. spoke with Pharmacist who reached out to GSK on the matter. GSK did not recommend revaccinating, as the vaccine is stable 30 days after expiration. patient did not have any reactions to this vaccine.
Headache, body aches, fever (highest measured temp of 100.8 F)
Information has been received from a pharmacist concerning a female who was inadvertently vaccinated with varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). It was noted that this was a staff error only, and not a product quality complaint. No further information was provided. Follow up information was received from the pharmacist who reported that the patient did not experience any symptoms. No further information is available.
vaccines excursion, administered to patient; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 5-year-old female patient who received DTPa-IPV (Kinrix) (batch number 34T2N, expiry date 7th May 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th May 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 13-MAY-2022 Reporters comment: Vaccine coordinator reported the vaccines excursion that was previous reported to be discarded, was administered to the patient in right thigh. The reporter did not consent to follow-up. Additional supportive information: The vaccine excursion that was previous reported to be discarded, was administered to the patient, which led to incorrect storage of drug. This was 1 of 3 linked cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022078360:Same reporter US-GLAXOSMITHKLINE-US2022078362:Same reporter
The patient was vaccinated with a dose of varicella virus vaccine live. Subsequently, in March 1999 the patient developed shingles. Unspecified medical attention was sought. It was reported that another patient had a similar experience following exposure to varicella virus vaccine live.
red, raised rash over torso and face over 4-5 days, benadryl given by primary care physician
PT RECEIVED 1ST DOSE OF PFIZER AT AGE 11. VACCINATOR DID NOT VERIFY AGE. NO ADVERSE REACTION NOTED AT TIME OF INJECTION. PARENT PRESENT AND INFORMED. ADVISED NOT TO RECEIVE 2ND UNTIL AFTER THE AGE OF 12.
Nov 6, 2011 Mother of patient walked into center, escorted by employee. Mother stated child "broke out with rash over body after getting vaccines from center". Mother stated she didn't want to fill out a report, "I'll take them to Hospital". VAERS report completed with info from immunization records.
Swelilng at the injection site; Pain at the injection site; Fever; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (Swelilng at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelilng at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and PYREXIA (Fever). At the time of the report, VACCINATION SITE SWELLING (Swelilng at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided.  No treatment medication was provided.
PATIENT REPORTED TO PHARMACY THAT SHE HAS BEEN HAVING PINS AND NEEDLES IN HER ARM AND THINK IT COULD BE FROM HER COVID-19 BOOSTER SHOT. SHE SAID AT FIRST, AFTER HER VACCINE, HER ARM WAS JUST SORE THEN AFTER ABOUT A WEEK SHE NOTICED PINS AND NEEDLES IN HER HAND AND ARM. SHE SAID IT SOMETIMES EVEN FEELS LIKE HER ARM IS ASLEEP. SHE SAID SYMPTOMS WAX AND WANE AND IF SHE MOVES HER ARM A CERTAIN WAY IT CAN MAKE THE PAIN WORSE. SHE HAS NOT SEEN A PHYSICIAN FOR EXAM YET, BUT IT HAS BEEN RECOMMENDED TO HER. SHE WAS ALSO ASKED TO KEEP THE PHARMACY UPDATED ON HER STATUS. AS OF 3 WEEKS LATER, SHE SAID HER CONDITION IS THE SAME IF NOT A BIT WORSE.
Ataxia possible cerebellitis. Required observation only. Medical records state leg pain. msv
Dizziness started 5 hours later, lasted 10 days, treated with prednisone.
Diarrhea 2-3 x daily > 7 days (+) Hx cholecystectomy (-) Risk or hospitalization (-) Abdominal pain Plan: Complete labs to assess for electrolyte abnormality ? CBC Brat Diet  12-14-2020 Covid positive
Nov. 1, 2011 client became fatigued and dizzy after 1st shot Hepatitis B vaccine. Within the week after the shot given her lip (upper) became swollen. She had a rash on (L) side , heart palpitation, flu like symptoms, and neck, shoulder and back pains. She also had an earache and ear ring in (L) ear.
Patient broke out with rash 1-4-06 had low grade fever.  Patient stayed home from school per nurse.  Will treat symptoms and return to regular activities when blisters heal.
Diarrhea; Coughing; Extreme Fatigue; Headache; could not breathe; Stomach was upset; she felt like she was suffocating before; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administration date 15Nov2021 15:46 (Lot number: FF2588) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st dose, Lot EN6200 , left arm in the muscle), administration date: 10Mar2021, when the patient was 55 years old, for COVID-19 Immunization; Bnt162b2 (2nd dose, Lot EN6204, right arm in the muscle), administration date: 31Mar2021, when the patient was 55 years old, for COVID-19 Immunization. The following information was reported: ASPHYXIA (medically significant) with onset Nov2021, outcome "unknown", described as "she felt like she was suffocating before"; COUGH (non-serious) with onset 15Nov2021, outcome "not recovered", described as "Coughing"; FATIGUE (non-serious) with onset 15Nov2021, outcome "recovering", described as "Extreme Fatigue"; HEADACHE (non-serious) with onset 15Nov2021, outcome "recovering", described as "Headache"; DIARRHOEA (non-serious) with onset 16Nov2021, outcome "recovering", described as "Diarrhea"; DYSPNOEA (non-serious) with onset Nov2021, outcome "unknown", described as "could not breathe"; ABDOMINAL DISCOMFORT (non-serious) with onset Nov2021, outcome "unknown", described as "Stomach was upset".  Follow-up attempts are completed. No further information is expected.
The refrigerator that houses the vaccines experienced a temperature excursion. Per the program, the PEDIARIX vaccine was considered to be out of range and therefore invalid.
Inappropriate Reconstitution Technique; Inappropriate Reconstitution Technique; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA912A, expiry date 28-FEB-2025) for prophylaxis.   On 20-MAY-2023, the patient received Menveo. On 20-MAY-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Inappropriate Reconstitution Technique) and inappropriate dose of vaccine administered (Verbatim: Inappropriate Reconstitution Technique). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 22-MAY-2023 Nurse Manager stated that a medical assistant administered only the liquid component of Menveo to a patient. Lot number provided was that of the diluent (which was not found in the batch identifier but was repeated and confirmed with HCP). The vaccine administration facility was the same as primary reporter. Consented to follow up via postal.
5 x 2 1/2cm red, warm & swollen area on lt arm;pt was put on cipro;
After receiving my second dose I was fine with a little pain at the injection site on 4/8 and 4/9. On Saturday, 4/10 I woke up feeling dizzy and my blood pressure was around 180/85. As the day progressed the dizziness turned to double vision and my blood pressure was 212/102. At about 3:30 PM I contacted my cardiologist who advised I go to the ER. Tests were run and they found that I had a Dorsal Pons stroke which caused the double vision due to lack of movement in my right eye.
Patient transported to acute care hospital for acute chest pain.  Diagnosed with acute pericardis.
7 months out from first vaccination for shingles.; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received first dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 08-JUN-2022 Reporter's Comments: The patient self-reported this case via interactive digital media. The patient realized that he/she was 7 months out from the first vaccination for shingles. The reporter asked if he/she needed to redo the first shot or could just get the second. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingles vaccine, which led to incomplete course of vaccination. The follow-up would not possible, as no contact, details were available.
On 10/10/11 patient was diagnosed with shingles (10/8/11 onset). She is on immune-suppressing medicine for RA. She is worried that her husband vaccine gave her the shingles. I advised her that there is no evidence of this in the literature.
Had well check yesterday and after receiving DTap on right leg immediately developed hives about 4in, given Benadryl. Developed fever up to 102 and vomiting. Rash has since gotten worse again today although better than yesterday right thigh with about 7cm diameter of multiple very erythematous mildly swollen papules, more confluent centrally.
Regression in speech and signs by May 2016, had lost all words and signs. Isolated play, extremely importance of routines and where items went, became extremely introverted, fears of people who he knew except parents and places he knew. Started having "fits"/outbursts, banging head, etc. when routine changed or out of his house or people were around (except parents), progression got worse to where doctors thought he was autistic, except they knew he was ahead of the curve prior to the vaccines given in August 2015. With intervention, things have improved, autism test negative, diagnosed with severe CAS...apraxia of speech and needs much more help.
Rash/Hives, itching, chest congestion, increase in pulse.  EMT called.
This spontaneous report was received from a registered nurse and refers to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not provided. On unknown dates, the patients were vaccinated with RECOMBIVAX HB lot number K010535, expiration date 27-AUG-2016 (route was not provided). Concomitant therapy information was not provided. On unknown dates, there was incorrect product storage as multiple unspecified patients received improperly stored RECOMBIVAX HB. The temperature was 47.98 F and the timeframe was 63 hours. No adverse event was not reported. At the time of the report, the patients' status was unknown. Additional information has been requested.
I had an extremely sore throat, worse than when I had strep throat years ago. It started Sunday and progressed to Monday evening when my son brought me an at-home COVID-19 test. At that time, I was running a fever 103.6F. The test came back positive unfortunately. The fever continued for about 2-3 days, so I contacted my pulmonologist. He prescribed me Paxlovid for my contraction of COVID-19; I started taking it day 3 of my symptoms, and 3 days later of taking the prescription, I started feeling way better. My temperature went back to normal body temperature and the sore throat had disappeared.
Left arm with 4cm erythematous and warm area with exudate or induration.  Left arm cellulitis.  Keflex 500mg 1 per mouth twice a day and Ibuprofen 600mg 1 per mouth twice a day.
Pt realized soreness, redness and swelling ("size of half a softball") on Left deltoid at injection site on the morning following the vaccination. Mom states area "felt warm", but by the time the child left for school it "no longer felt warm." Had not seen the doctor or applied ice to area or gave child any medication.
emesis; upset stomach; Sweating; headache; This is a spontaneous report from a contactable other healthcare professional. A 54-year-old female patient received the first dose of bnt162b2 (COVID-19 vaccine, brand: Pfizer) lot no: EK5730, intramuscular in left arm on 20Dec2020 09:30 at a single dose for Covid-19 immunization in a hospital. Medical history included allergies pineapple and coconut. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. Concomitant medication included warfarin sodium (JANTOVEN), sertraline, and metformin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took cefaclor (CECLOR) and zithromax (Z-PACK) and experienced allergies to both. On 20Dec2020, after the first shot, the patient experienced emesis within 40 minutes. Then on unspecified dates, the patient experienced upset stomach for 3 hours approximately, sweating and headache lasting about 4 hours. Treatment was not given for the events. The patient recovered from the events.
Mild swelling back of throat. Tonsils enlarged kept swallowing. Severe Pain at injection site. For about 1 wk. After 4 days itching at site and a lump
hard, red lump @ DTp site no tender, no drainage, site is deep red bruised-looking 28FEB94 small bruise @ site; o/wneg;
shortness of breath/difficulty breathing; panic attacks; rash on arms and legs; This is a spontaneous report from a contactable nurse, from a Pfizer-sponsored program.  A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 10Aug2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, the reporter was reporting a female patient had first dose of Pfizer Covid 19 vaccine on 10Aug2021 and then developed rash on arms and legs three days later. The nurse who is the vaccine provider explained that the patient also experienced shortness of breath/difficulty breathing but it was attributed to her baseline panic attacks and not the vaccine. Nurse further explained that the patient's HCP advised her not to get the second dose of the vaccine. Vaccine provider would like to know if her patient would be able to get the second dose given the side effects previously experienced. Nurse would like to know if there is an exemption form that can be provided for medical clearance. The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
02jul90 pt vax hepta B. pt devel n/v/d and low grade fever.  seen by md. viral illness dx.
diffuse erythematous rash in groin, thorax, axilla, and anterior legs
The evening of my second vaccine injection, I started feeling pain in my inner thigh/groin area. The pain started getting worse in the second week after the injection.  It hurt when I walked, sat, bent down to pick up something.  The second week after I also developed pain in my left arm on the outside of arm, but had pain when I lifted my arm.  The pain was worse at and through the night and in the morning, seemed to get a little better as I moved. The third week, the pain in my groin area had some relief while the pain in my arm spread to the other arm and both arms now have pain.  It is increased when I try to lift over my head making it difficult to wash, brush hair and also to get dressed.  Hurts more at night and in morning but once I get going seems to get better.  Starting 5/1/21 the pain came back in my leg and now continues to the other leg.  Both arms now are still hurting.  The left side seems to be worse, but both sides hurt.  I can't get comfortable when I sleep, so I am up tossing and turning.  Also hard to get in and out of bed and also up and down on furniture.
Client states per phone had seasonal f/u vaccine on Thurs 1/14/2010 and on 1/15/2010 felt bad-arm started itching from injection site down to elbow-broke out red on that arm only where shot was given it was the size of a dime (red) and arm was swollen some. I put ointment that I was given for a sore on my hip and it has helped. It is better today. My are was extremely sore, but soreness better today. I did have chills yesterday and felt weak, but feel better today. I feel its getting better, just wanted to make you aware. Advised client to come to clinic or see PMD if this worsens, states doesn't feel she needs to go now, feels its getting better, but if worsens will see PMD. Advised to let PMD aware  at next visit reaction she had and let him advise if she should receive one next year.
Shortly after midnight on New Years Eve had chills and fatigue, by the next day lymph node under left arm was swollen with a fever. On Monday morning got a call back from doctor to schedule a meeting on wednesday. (1/5) EKG, Blood, (Metabolic CBC and Thyroid) and it all came back normal. ECG schedule to be determined. Cardiologist referred and to be scheduled after heart monitor finishes.